IP Library Granted Patent US 7,835,790
Granted Patent B2
US 7,835,790 · App. 11/555,424 · Granted Nov 16, 2010

Anterior active housing subcutaneous positioning methods

Assignee: Cameron Health, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,835,790
App. No.
11/555,424
Granted
Nov 16, 2010
Kind
B2
Abstract

A subcutaneous cardiac device includes a subcutaneous electrode and a housing coupled to the subcutaneous electrode by a lead with a lead wire. The subcutaneous electrode is adapted to be implanted in a frontal region of the patient so as to overlap a portion of the patient's heart.

Claims (45)

1. A method of terminating a cardiac arrhythmia in a patient comprising delivering an electrical stimulus between at least first and second implanted electrodes wherein:

the first implanted electrode is disposed on a lead assembly;

the second implanted electrode is on a housing for an implantable cardioverter defibrillator;

the lead assembly is coupled to the implantable cardioverter defibrillator;

the housing is disposed on the left side of the patient's ribcage under the arm; and

the first implanted electrode is subcutaneously disposed at a substantially vertical subcutaneous position generally over the patient's heart, adjacent to the sternum.

2. The method of claim 1 , further comprising sensing cardiac activity in the patient.

3. The method of claim 1 , wherein the first implanted electrode is disposed on the left side of the sternum.

4. The method of claim 1 , wherein each implanted electrode used in the delivery of the electrical stimulus is disposed outside of the patient's ribcage.

5. A method of terminating a cardiac arrhythmia in a patient comprising delivering an electrical stimulus between at least first and second implanted electrodes wherein:

the first implanted electrode is disposed on a lead assembly;

the second implanted electrode is on a housing for an implantable cardioverter defibrillator;

the lead assembly is coupled to the implantable cardioverter defibrillator;

the housing is disposed at about the left inframammary crease of the patient; and

the first implanted electrode is subcutaneously disposed at a substantially horizontal position generally over the heart of the patient, generally superior to the housing, with both the housing and the first implanted electrode disposed on the left side of the patient's chest.

6. The method of claim 5 , further comprising sensing cardiac activity in the patient.

7. The method of claim 5 , wherein each implanted electrode used in delivery of the electrical stimulus is disposed outside of the patient's ribcage.

8. A method of terminating a cardiac arrhythmia in a patient comprising delivering an electrical stimulus between at least first and second implanted electrodes wherein:

the first implanted electrode is disposed on a lead assembly;

the second implanted electrode is on a housing for an implantable cardioverter defibrillator;

the lead assembly is coupled to the implantable cardioverter defibrillator;

the first implanted electrode is subcutaneously disposed at a substantially horizontal position over the patient's heart on the left side of the patient's chest;

the housing is disposed inferior of the patient's clavicle on the left side of the patient's body; and

the housing is disposed generally superior to the first implanted electrode.

9. The method of claim 8 , further comprising sensing cardiac activity in the patient.

10. The method of claim 8 , wherein each implanted electrode used in the delivery of the electrical stimulus is disposed outside of the patient's ribcage.

11. A method of terminating a cardiac arrhythmia in a patient comprising delivering an electrical stimulus between at least first and second implanted electrodes wherein:

the first implanted electrode is disposed on a lead assembly;

the second implanted electrode is on a housing for an implantable cardioverter defibrillator;

the lead assembly is coupled to the implantable cardioverter defibrillator;

the housing is disposed at about the left inframammary crease;

the first implanted electrode is subcutaneously disposed at a substantially vertical subcutaneous position over the heart, adjacent to the sternum; and

the housing is generally inferior to and left of the first implanted electrode.

12. The method of claim 11 , further comprising sensing cardiac activity in the patient.

13. The method of claim 11 , wherein the second implanted electrode is disposed on the left side of the sternum.

14. The method of claim 11 , wherein each implanted electrode used in the delivery of the electrical stimulus is disposed outside of the patient's ribcage.

15. A method of terminating a cardiac arrhythmia in a patient comprising delivering an electrical stimulus between at least first and second implanted electrodes wherein:

the first implanted electrode is disposed on a lead assembly;

the second implanted electrode is on a housing for an implantable cardioverter defibrillator;

the lead assembly is coupled to the implantable cardioverter defibrillator;

the housing is disposed on the left side of the patient's ribcage under the arm;

the first implanted electrode is disposed at a substantially horizontal position over the patient's heart; and

the housing is generally superior to and left of the first implanted electrode.

16. The method of claim 15 , further comprising sensing cardiac activity in the patient.

17. The method of claim 15 , wherein each implanted electrode used in the delivery of the electrical stimulus is disposed outside of the patient's ribcage.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2012
From: OSTROFF, ALAN H.
To: CAMERON HEALTH, INC.
Reel/Frame 029542/0569 →
AFFIRMATION OF ASSIGNMENT OF PAUL ERLINGER FOR US 7,149,575 AND RELATED CASES Recorded Dec 28, 2012
From: ERLINGER, PAUL
To: CAMERON HEALTH, INC.
Reel/Frame 029549/0296 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2011
From: OSTROFF, ALAN H.; ERLINGER, PAUL; BARDY, GUST H.
To: CAMERON HEALTH, INC.
Reel/Frame 026675/0757 →
Continuity (6)
Continuation 1015043400 · May 17, 2002
Continuation In Part 1001195600 · Nov 5, 2001
Continuation In Part 0994059900 · Aug 27, 2001
Continuation In Part 0966360700 · Sep 18, 2000
Continuation In Part 0966360600 · Sep 18, 2000
Related Publication 20070060960A1 · Mar 15, 2007